DZ-002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DZ-002, covering 2025-08-22 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]